Health Condition 1: R531- Weakness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.only patients having persistence of symptoms of chronic fatigue syndrome above 6 months are included for this study 2.patients of different socio-economic status and religion will be included 3.patients of age group 18yrs irrespective of sex are included for this study 4.patients willing to participate in clinical trial/ study with written consent 5. Pre diagnosed cases
Exclusion criteria
Exclusion criteria: 1.Immunocompromised patients and patients with complicated conditions that could confound results. 2.Patients undergoing any other form of treatment or medication for CFS 3.pregnant and lactating women 4.patients with gross pathological conditions 5.patients with other fatal and systemic complications 6. Hypersensitivity Reactions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in fatigue severity as measured by the 0-5 Rating Scale for Chronic Fatigue Syndrome. Assessments will be conducted at Baseline (Day 0), and subsequently at every follow-up visit (approximately every 4 weeks) throughout the 18-month study duration to monitor treatment efficacyTimepoint: Assessments will be recorded at Baseline (Day 0), followed by regular intervals every 15 to 30 days during follow-up visits, with a final evaluation at the completion of the 18-month study period. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Sonajirao Kshirsagar Homoeopathic Medical College Beed 431122